Found 5634 matching trials
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
N/A(Neo)adjuvant treatment approaches and outcomes...
Status
Active Not Recruiting
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
N/ALung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB
PHASE2The overall goal of this exploratory proof-of-concept study is to determine...
Location
Task Applied Science and Stellenbosch University
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers
N/AIn this prospective study, the investigators will implement a systematic sc...
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
PHASE2Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Location
Multiple Locations
Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC
PHASE2The PACIFIC study established the standard of care for immunotherapy consol...
Location
Multiple Locations
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
N/ATo estimate parameters related to clinical outcomes in a real-world seeting...
Status
Active Not Recruiting
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer
NAThe Personalized Discovery Process is the only program offering patients tr...
Location
Icahn School of Medicine at Mount Sinai
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
PHASE2A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
N/ARATIONALE: Studying samples of DNA in the laboratory from women who are BRC...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office